Search Results 361-370 of 16264 for monoclonal antibody

1. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability ... antibody), as measured from the last dose of bendamustine; relapsed ...

2. A Study to Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

3. Xinyan Wu, Ph.D. - Mayo Clinic Faculty Profiles

   Developing novel targeted therapies including humanized monoclonal antibody and antibody drug conjugate to target AXL receptor tyrosine kinase for triple ...

4. Hypereosinophilic Syndrome Clinical Trials

   Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, including ...

5. Mayo Clinic Uses New Approach to Reverse Multiple Sclerosis in Mice Models

   The monoclonal antibodies used in earlier research are large and complex, but were shown to promote both cell signaling and remyelination of central nervous ...

6. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma - Mayo Clinic

   RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...

7. Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

8. Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer ...

9. What experts know about COVID-19 omicron subvariant BA.2 - Mayo Clinic News Network

   ... monoclonal antibody therapies, and testing need further investigation. ... Multiple reports found that vaccine-induced antibodies could not bind to or neutralize ...

10. Clinical trials - Oncology (Medical)

    Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...